David Allen Jones Jr. - 20 Apr 2023 Form 4 Insider Report for HUMANA INC (HUM)

Role
Director
Signature
David A. Jones, Jr.
Issuer symbol
HUM
Transactions as of
20 Apr 2023
Net transactions value
$0
Form type
4
Filing time
20 Apr 2023, 10:58:36 UTC
Previous filing
02 Mar 2023
Next filing
02 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HUM Humana Common 380 20 Apr 2023 Direct F5
holding HUM Humana Common 800 20 Apr 2023 See Footnote F1
holding HUM Humana Common 32,440 20 Apr 2023 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HUM Restricted Stock Units 5,892 20 Apr 2023 Humana Common 5,892 Direct F2
holding HUM Restricted Stock Units 95 20 Apr 2023 Humana Common 95 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

David Allen Jones Jr. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares held in two trusts for the benefit of reporting person's son/daughter, respectively, in each case where the reporting person is the sole trustee.
F2 Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F3 Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
F4 Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock.
F5 Includes 380 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/23. Total shares received will be pro-rated based on number of months served on the Board prior to separation.